List view / Grid view
18 June 2015 | By Victoria White
Findings from ImmunoGen’s preclinical assessments of IMGN529 in combination with rituximab have been presented at ICML 2015...
17 June 2015 | By Victoria White
Anika Therapeutics is set to collaborate with the Institute for Applied Life Sciences at UMass to develop a therapy for rheumatoid arthritis (RA)...
17 June 2015 | By Victoria White
GSK is making a substantial investment to launch the Altius Institute for Biomedical Sciences (Altius), an independent, non-profit research institute...
17 June 2015 | By Victoria White
Researchers at Lawson Health Research Institute have identified a new stem cell population in the colon linked to colon cancer growth...
17 June 2015 | By Victoria White
AstraZeneca is to collaborate with Inserm to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD)...
17 June 2015 | By Victoria White
A new study suggests 15-PGDH shows promise as a drug target to help tissue regeneration, particularly after bone marrow transplantation and tissue injuries...
16 June 2015 | By Victoria White
Researchers from the Johns Hopkins Bloomberg School of Public Health have located a new target for a potential vaccine against malaria...
16 June 2015 | By Victoria White
Chemists have invented the first practical, scalable method for synthesising jiadifenolide, a molecule that may have powerful brain-protecting properties...
16 June 2015 | By Victoria White
Rapamycin, a pharmaceutical used to coat coronary stents and prevent transplant rejection, reduces obesity and preserves lean body mass when given to rats...
16 June 2015 | By Victoria White
Researchers have found that a hormone called urocortin 3 is released at the same time as insulin and acts to damp down insulin production...
16 June 2015 | By Victoria White
Scientists have established conclusively that a protein called “Rhes” plays a pivotal role in focusing the toxicity of Huntington’s in the striatum...
16 June 2015 | By Victoria White
Marks & Blerk’s latest report highlights the striking difference between research levels into rare diseases, vaccines and antibiotics across the globe...
16 June 2015 | By Victoria White
Agalimmune has licensed KODE Biotech’s Function-Spacer-Lipid (FSL) cell surface membrane modification technology (KODE™ Technology)...
15 June 2015 | By Victoria White
Researchers have found that modulation of B lymphocyte function may be a means of regulating T lymphocyte function to treat immune-mediated disorders...
15 June 2015 | By Victoria White
Scientists at Helmholtz Zentrum München have discovered that Epstein-Barr virus (EBV) conceals itself in human cells using the LMP2A protein.
